The Joint Commission
[HAP Small] Acute Care Hospitals (2022)
CY2023 ORYX Requirements for [HAP Small] Acute Care Hospitals
How are [HAP Small] Acute Care Hospitals defined as it relates to ORYX Requirements?
For The Joint Commission, ORYX performance measurement requirements are specifically applicable to organizations accredited under the Hospital Accreditation Program (HAP).
HAP Small are defined as <26 Licensed beds AND<50,000 Outpatient visits
Refer to your Joint Commission Connect Site eAPP Hospital Volume or view the DDSP HCO Characteristics Organization Requirements tab for licensed bed / outpatient volume information.
eCQMs are submitted for three (3) quarters.
Chart-abstracted measures are submitted for four (4) quarters. unless otherwise noted.
In order to meet ORYX requirements, submitted measures must be applicable to patient population/services offered.
HAP Small] Hospitals with <26 Licensed beds AND < 50,000 Outpatient visits |
---|
REQUIRED: Submit any three (3) measures (chart-abstracted measures and/or eCQMs) applicable to patient population/ services offered.
|
AVAILABLE eCQMs: |
eED-2 (eCQM) Admit Decision Time to ED Departure-Admit |
eOPI-1 (eCQM) Safe Use of Opioids |
ePC-01 (eCQM) Elective Delivery |
ePC-02 (eCQM): Cesarean Birth |
ePC-05 (eCQM) Exclusive Breast Milk Feeding |
ePC-06 (eCQM) Unexpected Complications in Term Newborns |
ePC-07 (eCQM) Severe Obstetric Complications |
eSTK-2 (eCQM) Discharged on Antithrombotic Therapy |
eSTK-3 (eCQM) Anticoagulation Therapy Atrial Fibrillation/Flutter |
eSTK-5 (eCQM) Antithrombotic Therapy by End of Hospital Day 2 |
eSTK-6 (eCQM) Discharged on Statin Medication |
eVTE-1 (eCQM) Venous Thromboembolism Prophylaxis |
eVTE-2 (eCQM) ICU Venous Thromboembolism Prophylaxis |
OPTIONAL Chart-Abstracted Measures |
ED-1 (CAM) Median ED Arrival to ED Departure-Admit |
ED-2 (CAM) Admit Decision Time to ED Departure-Admit |
HBIPS-1 (CAM) Admission Screening |
HBIPS-2 (CAM) Hours of Physical Restraint Use |
HBIPS-3 (CAM) Hours of Seclusion Use |
HBIPS-5 (CAM) Antipsychotic Medications at Discharge |
IMM-2 (CAM) Influenza Immunization NOTE: IMM-2 is a seasonal measure; only 1Q and 4Q data are submitted |
OP-18 (CAM) Median ED Arrival-ED Departure at Discharge |
OP-23 (CAM) Head CT or MRI Scan Results-Stroke |
PC-01 (CAM): Elective Delivery |
PC-02 (CAM): Cesarean Birth |
ePC-06 (CAM): Exclusive Human Milk Feeding |
PC-06 (CAM): Unexpected Complications in Term Newborns |
SUB-2 (CAM) Alcohol Use Brief Intervention |
SUB-3 (CAM) Alcohol & Drug Use Treatment at Discharge |
TOB-2 (CAM) Tobacco Use Treatment |
TOB-3 (CAM) Tobacco Use Treatment at Discharge |
VTE-6 (CAM) Hospital Acquired Potentially-Preventable VTE |
©The Joint Commission, All Rights Reserved
The Joint Commission is a registered trademark of The Joint Commission.